期刊文献+

microRNA-32在肾透明细胞癌患者肿瘤组织中表达临床意义

Clinical significance of microR-32 expression in tumor tissue of suprarenal epithelioma patient
在线阅读 下载PDF
导出
摘要 目的研究micro RNA-32(miR-32)在肾透明细胞癌(SE)患者肿瘤组织中表达及与SE病理分级的关系。方法选择76例于青海大学附属医院泌尿外科收治的SE患者,其中男性48例,女性28例;年龄38~65岁,平均年龄53.44岁;TNM分期,Ⅰ期14例,Ⅱ期20例,Ⅲ~Ⅳ期42例;肿瘤直径<4 cm 44例,≥4 cm 32例。取手术后病灶组织和癌旁组织,采用实时荧光定量聚合酶链反应检测miR-32、miR-21在肿瘤组织及癌旁组织中的表达,分析miR-32与SE患者病理特征的关系;采用Pearson相关性检验分析miR-32与miR-21相关性;采用Western blot检测SE组织及癌旁组织中纤维状肌动蛋白(F-actin)、磷酸酶张力蛋白同源基因(PTEN)、波形蛋白(vimentin)的表达。结果 SE患者肿瘤组织中miR-32、miR-21表达明显高于癌旁组织(P<0.05);与肿瘤直径<4 cm相比,SE患者肿瘤直径≥4 cm肿瘤组织中miR-32表达升高,且随TNM分期升高而升高。Pearson相关性分析结果显示肿瘤组织中miR-32与miR-21表达呈正相关(r=0.627,P<0.05)。与癌旁组织相比,SE肿瘤组织中F-actin、vimentin表达升高,PTEN表达降低(P<0.05)。结论 miR-32在SE肿瘤组织中呈高表达,并且与肿瘤直径、临床分析密切相关,其机制可能与miR-32可促进SE细胞迁移有关。 Objective To study the expression of micro RNA-32( mi R-32) in tumor tissues of patients with suprarenal epithelioma(SE) and the relationship with pathological grade of SE. Methods A total of 76 SE patients undergoing urology treatment were enrolled, which included 48 males and 28 females, aged 38-65 years old with mean age of 53.44 years old. In TNM staging, 14 cases of stage Ⅰ, 20 of stage Ⅱ and 42 of stage Ⅲ-Ⅳ; 44 cases of tumor with diameter 4 cm and 32 cases 4 cm. Real-time PCR was used to detect the expression of mi R-32 and mi R-21 in post-operative lesion tissue and paracancerous tissue. The relationship between mi R-32 and pathological features of SE was analyzed. Pearson correlation test was used to analyze the correlation between mi R-32 and mi R-21; Western blot was used to detect the expression of fibrillar actin(F-actin), phosphatase tension protein homologue(PTEN) and vimentin(vimentin) in SE tissues and adjacent tissues.Results The expression of mi R-32 and mi R-21 in tumor tissues of the SE patients was significantly higher than that in ad-jacent tissue(P 0.05). Compared with tumor diameter 4 cm, the expression of mi R-32 in tumors with diameter ≥ 4 cm increased in SE patients, with the increase of the TNM staging; Pearson correlation analysis showed that there was a positive cor-relation between the expression of mi R-32 and mi R-21 in tumor tissues(r = 0.627, P 〈0.05). Compared with the adjacent tissue, the expression of F-actin and vimentin was increased and the expression of PTEN was decreased in SE tumor tissues( P 〈0.05). Conclusion It is demonstrated that mi R-32 is highly expressed in tumor tissue of SE and is closely related to tumor diameter and clinical analysis. The possible mechanism may be that mi R-32 promotes the migration of SE cells.
作者 唐以众 吴冠林 王明岗 鲜武 王健 TANG Yi-zhong;WU Guan-lin;WANG Ming-gang;XIAN Wu;WANG Jian(Affiliated Hospital of Qinghai University,Xining 810016,Qinghai,China;Qinghai Transportation Hospital,Xining 810001,Qinghai,China)
出处 《生物医学工程与临床》 CAS 2018年第4期453-456,共4页 Biomedical Engineering and Clinical Medicine
基金 青海省教育厅科学技术研究项目(GJJ15623)
关键词 肾透明细胞癌 微小核糖核酸-32 迁移 肿瘤 纤维状肌动蛋白 suprarenal epithelioma microRNA -32 migration tumor fibrous actin
作者简介 唐以众(1973-),男,青海海东市人,硕士,主治医师,主要从事肾脏肿瘤发病机制及治疗研究。电话:13709768878。E-mail:qhtgteam@163.com。
  • 相关文献

参考文献8

二级参考文献43

  • 1姚晓军,胡以则,黄仲初.PTEN在肝细胞癌中的表达及其与VEGF的关系研究[J].广东医学,2006,27(3):339-341. 被引量:3
  • 2张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:人民卫生出版社,2007:134-138.
  • 3El-Scrag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis [ J ]. Gastroenterology, 2007, 132 (7) : 2557 -2576.
  • 4Padma S, Martinie JB, Iannitti DA. Liver tumor ablation : percutaneous and open approaches [J]. J Surg Oncol, 2009, 100(8) : 619-634.
  • 5Cha CH, Saif MW, Yamane BH, et al. Hepatocellular carcinoma: current management [J]. Curr Probl Surg, 2010, 47(1): 10-67.
  • 6Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? [J]. RNA, 2005, 11(12) : 1753-1761.
  • 7Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes [J]. Cell, 2006, 126(6): 1203-1217.
  • 8Schmittgen TD. Regulation of microRNA processing in development, differentiation andcance [J]. JCellMolMed, 2008, 12(5B): 1811- 1819.
  • 9Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cance [ J]. Cell Cycle, 2008, 7 (17) : 2643-2646.
  • 10Aravalli RN, Steer C J, Cressman EN. Molecular mechanisms of hepatocellular carcinoma [ J]. Hepatology, 2008, 48 (6) : 2047-2063.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部